Actionable news
0
All posts from Actionable news
Actionable news in BLCM: BELLICum PHARMACEUTICALS Inc,

Bellicum Pharmaceuticals`s Options Are Worth Considering Prior To Earnings

Bellicum Pharmaceuticals, Inc. (BLCM) is a clinical-stage biopharmaceutical company. The Company is focused on discovering and developing cellular immunotherapies for various forms of cancer, including hematological cancers and solid tumors, as well as orphan inherited blood disorders. The Company uses its chemical induction of dimerization (CID) technology platform to engineer and then control components of the immune system. The Company is developing next-generation product candidates in the areas of cellular immunotherapy, including hematopoietic stem cell transplantation (HSCT), chimeric antigen receptors (CAR) T cells therapy and T-cell receptor (TCR) cell therapies. It is reporting earnings on Monday, August 8, after market close:

As evident from the above, the company beat earnings estimates in 16% of time in the...


More